# Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

> **NCT05504265** · PHASE2,PHASE3 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 102 (estimated)

## Conditions studied

- Esophageal Cancer
- Perioperative Analgesia
- NSAIDs
- Opioid
- Patient-controlled Analgesia

## Interventions

- **DRUG:** Preemptive flurbiprofen axetil
- **DRUG:** Postoperative flurbiprofen axetil
- **DEVICE:** Patient-controlled analgesia pump

## Key facts

- **NCT ID:** NCT05504265
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-10
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-20
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05504265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05504265, "Perioperative Analgesia Modes in Minimally Invasive Esophagectomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05504265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*